The Heartline Experience: Achieving Long-Term Participant Engagement in Digital Health Technology Trials. [PDF]
Nikolovski J +16 more
europepmc +1 more source
Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma. [PDF]
Sebastian T +22 more
europepmc +1 more source
A study to learn how well enfortumab vedotin (EV) with pembrolizumab works and how safe it is in people with advanced urothelial cancer: a plain language summary of the EV-302/KEYNOTE-A39 study. [PDF]
Powles T +23 more
europepmc +1 more source
Artificial intelligence for algorithmic trading digital assets: evidence from the Counter-Strike 2 skin market. [PDF]
Guede-Fernández F +6 more
europepmc +1 more source
Targeting the EZH2-SLFN11 pathway-a lesson in developing molecularly-informed treatments for recurrent small cell lung cancer. [PDF]
Sun F, Das MS.
europepmc +1 more source
Analyzing health outcomes measured as bounded counts. [PDF]
Mullahy J.
europepmc +1 more source
Reporting of primary endpoint and associated spin in randomized myeloma trials. [PDF]
Singstock M +5 more
europepmc +1 more source
A comprehensive review and comparison of existing computational methods for protein function prediction. [PDF]
Lin B, Luo X, Liu Y, Jin X.
europepmc +1 more source
Forecasting Trends in Androgen Deprivation Therapy Intensification for Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Population-Based Cohort and Time-Series Analysis. [PDF]
Khosh Kish E +18 more
europepmc +1 more source

